Literature DB >> 21327446

Complications of loco-regional therapy in the liver-spectrum of imaging findings by CT and MRI.

David Bonekamp1, Diane K Reyes, Susanne Bonekamp, Tamara A Wahlin, Jean-Francois H Geschwind, Elliot K Fishman, Ihab R Kamel.   

Abstract

The aim of this study was to discuss the appearance of common complications from loco-regional therapy of primary and secondary malignant liver neoplasms on cross-sectional imaging. Knowledge of common complications is important for the safe performance of loco-regional therapy (LRT) and for the interpretation of post-LRT follow-up imaging. With careful patient selection, LRT represents an effective and safe treatment of primary and secondary hepatic malignancies; however, complications related to LRT methods infrequently lead to additional morbidity.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21327446      PMCID： PMC4332777          DOI： 10.1007/s10140-011-0942-y

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN： 1070-3004


  13 in total

1.  Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer.

Authors:  Jinglin Xia; Zhenggang Ren; Shenglong Ye; Dilip Sharma; Zhiying Lin; Yuhong Gan; Yi Chen; Ninglin Ge; Zengchen Ma; Zhiquan Wu; Jia Fan; Lunxiu Qin; Xinda Zhou; Zhaoyou Tang; Binghui Yang
Journal:  Eur J Radiol       Date:  2006-04-18       Impact factor: 3.528

2.  Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.

Authors:  Giammaria Fiorentini; Camillo Aliberti; Gina Turrisi; Alessandro Del Conte; Susanna Rossi; Giorgio Benea; Petros Giovanis
Journal:  In Vivo       Date:  2007 Nov-Dec       Impact factor: 2.155

3.  The blood supply of neoplasms in the liver.

Authors:  C BREEDIS; G YOUNG
Journal:  Am J Pathol       Date:  1954 Sep-Oct       Impact factor: 4.307

4.  Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

Authors:  Daniel B Brown; Jean-Francois H Geschwind; Michael C Soulen; Steven F Millward; David Sacks
Journal:  J Vasc Interv Radiol       Date:  2009-07       Impact factor: 3.464

5.  Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors.

Authors:  Jean-Francois H Geschwind; Shaifali Kaushik; Douglas E Ramsey; Michael A Choti; Elliot K Fishman; Hicham Kobeiter
Journal:  J Vasc Interv Radiol       Date:  2002-11       Impact factor: 3.464

6.  Risk factors for liver abscess formation after hepatic chemoembolization.

Authors:  W Kim; T W Clark; R A Baum; M C Soulen
Journal:  J Vasc Interv Radiol       Date:  2001-08       Impact factor: 3.464

7.  Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome.

Authors:  S Y Song; J W Chung; J K Han; H G Lim; Y H Koh; J H Park; H S Lee; C Y Kim
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

Review 8.  Chemoembolization of hepatic malignancy.

Authors:  Carin F Gonsalves; Daniel B Brown
Journal:  Abdom Imaging       Date:  2009 Sep-Oct

9.  Liver metastases of neuroendocrine tumors: treatment with hepatic transarterial chemotherapy using two therapeutic protocols.

Authors:  Thomas J Vogl; Tatjana Gruber; Nagy N N Naguib; Renate Hammerstingl; Nour-Eldin A Nour-Eldin
Journal:  AJR Am J Roentgenol       Date:  2009-10       Impact factor: 3.959

10.  Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.

Authors:  Giada Pietrosi; Roberto Miraglia; Angelo Luca; Giovanni Battista Vizzini; Daniela Fili'; Volpes Riccardo; Adele D'Antoni; Ioannis Petridis; Luigi Maruzzelli; Domenico Biondo; Bruno Gridelli
Journal:  J Vasc Interv Radiol       Date:  2009-06-04       Impact factor: 3.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.